Evidence map›Paper›PMID 37614242›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease.

Stacey J Sukoff Rizzo, Gregg Homanics, David J Schaeffer, Lauren Schaeffer, Jung Eun Park, Julia Oluoch, Tingting Zhang, Annat Haber, Nicholas T Seyfried, Benedict Paten and 8 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A Complete Genome for the Common Marmoset.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  19. Review
  20. An open access resource for marmoset neuroscientific apparatus.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Stacey J Sukoff RizzoUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Gregg HomanicsUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
David J SchaefferUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Lauren SchaefferUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Jung Eun ParkUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Julia OluochUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Tingting ZhangUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Annat HaberThe Jackson Laboratory Bar Harbor Maine USA.
Nicholas T SeyfriedDepartment of Biochemistry Emory University School of Medicine Atlanta Georgia USA.
Benedict PatenUniversity of California Santa Cruz Genomics Institute University of California Santa Cruz Santa Cruz California USA.
Anna GreenwoodSage Bionetworks Seattle Washington USA.
Takeshi MuraiUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Sang Ho ChoiUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Hasi HuheUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Julia KoflerUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Peter L StrickUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
Gregory W CarterThe Jackson Laboratory Bar Harbor Maine USA.
Afonso C SilvaUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
University of Pittsburgh · USJackson Laboratory · USEmory University · USSage Bionetworks · USUniversity of California, Santa Cruz · US

Funding

TREAT AD Structural Biology CoreU54AG065187 · NIA · EMORY UNIVERSITY · PI Gregory W Carter, ALLAN I LEVEY · 2019 to 2026
$69.7M
Veterinary and Colony Management CoreU19AG074866 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Stacey J Rizzo · 2022 to 2026
$44.9M
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau SeedingR24AG073190 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SILVA, AFONSO C · 2021 to 2024
$4.5M
NIA NIH HHS R24 AG073190NIA NIH HHS U19 AG074866NIA NIH HHS U54 AG065187
6 · The paper itself

Abstract

Introduction: Our limited understanding of the mechanisms that trigger the emergence of Alzheimer's disease (AD) has contributed to the lack of interventions that stop, prevent, or fully treat this disease. We believe that the development of a non-human primate model of AD will be an essential step toward overcoming limitations of other model systems and is crucial for investigating primate-specific mechanisms underlying the cellular and molecular root causes of the pathogenesis and progression of AD. Methods: A new consortium has been established with funding support from the National Institute on Aging aimed at the generation, characterization, and validation of Marmosets As Research Models of AD (MARMO-AD). This consortium will study gene-edited marmoset models carrying genetic risk for AD and wild-type genetically diverse aging marmosets from birth throughout their lifespan, using non-invasive longitudinal assessments. These include characterizing the genetic, molecular, functional, behavioral, cognitive, and pathological features of aging and AD. Results: The consortium successfully generated viable founders carrying Discussion: By establishing marmoset models of AD, we will be able to investigate primate-specific cellular and molecular root causes that underlie the pathogenesis and progression of AD, overcome limitations of other model organisms, and support future translational studies to accelerate the pace of bringing therapies to patients.

Indexed as

Alzheimer's diseaseanimal modelsbiomarkerscognitiongenetic engineeringiPSCmarmosetmulti‐omicsPSEN1

Identifiers

PMID37614242
PMCPMC10442521
OpenAlexW4386053261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.